Cardiovascular Outcomes Trials in Type 2 Diabetes Mellitus

Publisher： Karger

E-ISSN： 1421-9751|135|2|108-126

ISSN： 0008-6312

Source： Cardiology, Vol.135, Iss.2, 2016-06, pp. : 108-126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials

By Allemann Sabin   Diem Peter   Egger Matthias   Christ Emanuel R.   Stettler Christoph  

Current Medical Research and Opinion, Vol. 22, Iss. 3, 2006-03 ,pp. : 617-623

Informa Healthcare

Access to resources Recommend Favorite

Multifactorial Lifestyle Interventions in the Primary and Secondary Prevention of Cardiovascular Disease and Type 2 Diabetes Mellitus—A Systematic Review of Randomized Controlled Trials

By Angermayr Lucia  

Annals of Behavioral Medicine, Vol. 40, Iss. 1, 2010-08 ,pp. : 49-64

Springer Publishing Company

Access to resources Recommend Favorite

Cardiovascular disease and type 2 diabetes mellitus: A multifaceted symbiosis

By Johansen O. E.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 8, 2007-01 ,pp. : 786-800

Informa Healthcare

Access to resources Recommend Favorite

Type 2 diabetes mellitus and bone

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 283, Iss. 2, 2018-02 ,pp. : 140-153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 620-628

John Wiley & Sons Inc

Access to resources Recommend Favorite